IDEXX Laboratories revenue and financials

IDXX · NASDAQ · USD

$515.41−2.21%−$11.66

Close · October 6, 2026

In the fiscal year ended December 2025, IDEXX Laboratories reported revenue of $4.3B (+10.42% year over year). Net income was $1.06B, a net margin of 24.6%.

Annual revenue · 2025: $4.3B

$1.78B2016
$1.97B2017
$2.21B2018
$2.41B2019
$2.71B2020
$3.22B2021
$3.37B2022
$3.66B2023
$3.9B2024
$4.3B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: +10.42%; 2025 vs 2024
Net income growth: +19.33%; 2025 vs 2024
Net margin: 24.6%; 2024: 22.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	1,217	1,141	1,091	1,105	1,109	998	954	976	1,004	964	902	916
Cost of revenue	437	418	432	422	415	375	384	380	384	371	375	368
Gross profit	779	723	658	683	695	623	571	596	619	593	526	548
Selling, general and administrative	288	294	267	265	260	257	251	238	238	241	229	225
Research and development	65.4	65.8	66.8	63.4	61.9	59.1	57.7	54.0	55.5	52.6	51.8	48.0
Operating income	426	363	325	355	373	308	262	304	325	299	245	275
EBIT	426	363	325	355	373	308	262	304	325	299	245	275
EBITDA	467	400	363	391	409	342	295	338	357	329	275	304
Interest expense	10.2	7.7	9.2	10.7	11.3	7.7	7.5	7.7	8.1	7.9	9.3	8.6
Pre-tax income	417	355	307	345	362	310	256	299	259	295	240	268
Income tax	78.8	77.0	58.8	70.2	68.4	67.4	40.2	66.1	55.8	59.9	45.1	55.7
Net income	338	278	248	275	294	243	216	233	203	236	195	212
Net income to common shareholders	338	278	248	275	294	243	216	233	203	236	195	212
Basic EPS	4.29	3.50	3.11	3.43	3.66	2.98	2.64	2.83	2.46	2.84	2.34	2.55
Diluted EPS	4.27	3.47	3.09	3.40	3.63	2.96	2.62	2.80	2.44	2.81	2.31	2.53
Average shares (basic)	79.0	79.6	79.9	80.1	80.4	81.3	81.8	82.3	82.6	83.1	83.1	83.1
Average shares (diluted)	79.3	80.2	80.5	80.7	81.0	81.9	82.5	83.1	83.4	84.0	83.9	84.0